"The winners in life are differentiated from the losers in life because the winners never fall," Albert Bourla says. "The ...

Albert Bourla admitted to going to extreme lengths to “save the world” and get the vaccines out faster during the COVID-19 ...

Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum. Learn more about PFE stock now.

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...

Pfizer is one of the world's largest pharmaceutical companies. Even after losing more than half of its value, it still has a ...

But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good ...

Pfizer Inc. has a 6% yield and 8.49x P/E with new cancer drugs and GLP-1 therapies to offset 2026-2028 LOE cycles. Read why ...

The appeal stems from Pfizer’s challenge to the Madras High Court’s decision, which declined to assist in enforcing the US ...

The 2025-26 Pfizer COVID-19 vaccine is about 57% effective against emergency department/urgent care (ED/UC) visits and 54% ...